154 related articles for article (PubMed ID: 161668)
1. Fibrin suspension as a substrate fop plasmin: determination and kinetics.
Kanai S; Okamoto H; Tamaura Y; Yamazaki S; Inada Y
Thromb Haemost; 1979 Dec; 42(4):1153-8. PubMed ID: 161668
[TBL] [Abstract][Full Text] [Related]
2. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen assay by means of the lysis time method.
Berg W; Korsan-Bengtsen K; Ygge J
Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
[TBL] [Abstract][Full Text] [Related]
5. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
6. Plasmin potency estimates: influence of the substrate used in assay.
Philo RD; Gaffney PJ
Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
9. [Ultramicro determination of plasmin using fibrin plate. 1. Determination of plasmin activity].
Miyatani K; Fukui I
Rinsho Byori; 1971 Sep; 19(9):641-4. PubMed ID: 4258462
[No Abstract] [Full Text] [Related]
10. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
12. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
Castro MJ; Kingston IB; Anderson S
Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
[TBL] [Abstract][Full Text] [Related]
13. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
Teisseyre E; Latallo ZS; Kopeć M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
[No Abstract] [Full Text] [Related]
14. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
Schwartz LB; Bradford TR; Littman BH; Wintroub BU
J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
[TBL] [Abstract][Full Text] [Related]
15. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
Nanninga LB
Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
[TBL] [Abstract][Full Text] [Related]
16. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
17. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
18. [New methods of studying the plasmin system using azofibrin].
Monastyrskiĭ VA; Gaĭda AV; Danysh TV; Magerovskiĭ IuV
Lab Delo; 1988; (10):49-53. PubMed ID: 2462090
[No Abstract] [Full Text] [Related]
19. Spectrophotometrical determination of plasminogen and plasmin inhibitors in human plasma using fibrin suspension as a substrate.
Saito Y; Kanai S; Takabayashi K; Inada Y
Thromb Res; 1980 Nov; 20(3):307-13. PubMed ID: 6451951
[No Abstract] [Full Text] [Related]
20. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
Johnson AJ; Tse A; Skoza L
Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
